India
India is an essential partner of the Global Fund. Since its inception in 2002, the Global Fund has consistently supported India’s fight against AIDS, tuberculosis and malaria, while India’s leading pharmaceutical and technology companies have been invaluable contributors to the Global Fund’s lifesaving impact around the world.
As a donor, India has pledged more than US$120 million to the Global Fund. It pledged US$30 million for the Global Fund’s Eighth Replenishment in November 2025, representing a 20% increase over India’s contribution for the previous cycle.
Pledges and contributions
Data updated on: 12 August 2026
Cumulative
Total pledged
US$124.5 million
Total contributed
US$93.5 million
Eighth Replenishment (2026-2028)
Total pledged
US$30 million
Total contributed
US$0
Pledges and contributions by replenishment
India and the Global Fund
Global health is among India’s top international cooperation priorities. The Government of India, led by Prime Minister Narendra Modi, has shown unprecedented leadership in fighting infectious diseases. Its efforts to eliminate tuberculosis, in particular, have set global standards. India also plays a leading role prioritizing global health issues on the agendas of the G20 and BRICS.
Indian corporations are driving innovation and serve as critical suppliers of quality and affordable health products, including pharmaceuticals, mosquito nets and diagnostic tests, for programs funded by the Global Fund. India and the Global Fund also share the objective of harnessing digital tools, including those integrating artificial intelligence, to maximize health outcomes. The Global Fund currently invests over US$150 million per year in initiatives that help countries around the world better capture, integrate, analyze and use data.